Chugai Pharmaceutical Co., Ltd. (TYO:4519)
6,933.00
-242.00 (-3.37%)
Aug 14, 2026, 3:30 PM JST
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of 11.41 trillion as of August 14, 2026. Its market cap has increased by 10.81% in one year.
Market Cap
11.41T
Enterprise Value
10.44T
Revenue
1.34T
Ranking
n/a
PE Ratio
24.21
Stock Price
6,933.00
ChartMarket Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 310.35B to 11.41T, an increase of 3,575.44%. That is a compound annual growth rate of 10.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 11.41T | -15.91% |
| Dec 30, 2025 | 13.57T | 17.79% |
| Dec 30, 2024 | 11.52T | 31.04% |
| Dec 29, 2023 | 8.79T | 58.64% |
| Dec 30, 2022 | 5.54T | -9.78% |
| Dec 30, 2021 | 6.14T | -32.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Otsuka Holdings | 6.53T |
| Daiichi Sankyo Company | 5.04T |
| Astellas Pharma | 4.17T |
| Kyowa Kirin | 1.37T |
| Ono Pharmaceutical | 1.14T |
| Santen Pharmaceutical | 630.82B |
| JCR Pharmaceuticals | 64.31B |
| Perseus Proteomics | 2.71B |